October 27, 2016 6:40 PM ET


Company Overview of Ligand Pharmaceuticals Incorporated

Executive Profile

Roland Buelow Ph.D.

Vice President of Antibody Technologies, Ligand Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Roland Buelow, Ph.D. serves as a Vice President of Antibody Technologies at Ligand Pharmaceuticals Incorporated. Prior to joining Ligand in 2015, Dr. Buelow founded Open Monoclonal Technology, Inc. in 2005 and served as its Chief Executive Officer. Dr. Buelow was a founder of THP Inc., a biotechnology company which engineered rabbits to produce human antibodies and was acquired by Roche in March 2007. Dr. Buelow served as Chief Scientific Officer and Director of ...

Corporate Headquarters

11119 North Torrey Pines Road
La Jolla, California 92037

United States

Phone: 858-550-7500
Fax: --

Board Members Memberships

Founder, Chief Executive Officer and Director


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Joseph C. Papa Chairman of the Board and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director, Director and Chairman of Executive Committee
Shire plc
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Timothy P. Walbert Chairman, Chief Executive Officer and President
Horizon Pharma plc
Mark Christopher Trudeau Chief Executive Officer, President, Director and Member of Portfolio Committee
Mallinckrodt Public Limited Company
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ligand Pharmaceuticals Incorporated, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.